- University of Pittsburgh, Department of Biological Sciences, Kenneth P. Dietrich School of Arts and Sciences, Pittsburgh, PA, United States
Stage conversion is a critical life cycle feature for several Apicomplexan parasites as the ability to switch between life forms is critical for replication, dissemination, pathogenesis and ultimately, transmission to a new host. In order for these developmental transitions to occur, the parasite must first sense changes in their environment, such as the presence of stressors or other environmental signals, and then respond to these signals by initiating global alterations in gene expression. As our understanding of the genetic components required for stage conversion continues to broaden, we can better understand the conserved mechanisms for this process and unique components and their contribution to pathogenesis by comparing stage conversion in multiple closely related species. In this review, we will discuss what is currently known about the mechanisms driving stage conversion in Toxoplasma gondii and its closest relatives Hammondia hammondi and Neospora caninum. Work by us and others has shown that these species have some important differences in the way that they (1) progress through their life cycle and (2) respond to stage conversion initiating stressors. To provide a specific example of species-specific complexities associated with stage conversion, we will discuss our recent published and unpublished work comparing stress responses in T. gondii and H. hammondi.
Introduction
Eukaryotic parasites with multi-host life cycles have the unique challenge of persisting in a variety of different environments. Parasites of this nature must exist in a life form that is permissible and optimized for growth, survival, and transmission in a given host. The ability to adopt these specific life forms is especially critical for tissue cyst forming coccidia in the Sarcocystidae family which includes Sarcocystis, Frenkelia, Besnoitia, Cystoisopora, Toxoplasma, Hammondia, and Neospora species (Smith, 1981; Duszynski et al., 2018). Here, we will discuss the current knowledge about how three closely related parasites from this family, Toxoplasma gondii, Hammondia hammondi, and Neospora caninum, approach the challenges associated with multi-host life cycles. These three mammalian parasites follow heteroxenous, two host life cycles (Frenkel et al., 1970; Frenkel and Dubey, 1975; McAllister et al., 1998; Dubey, 2009; Dubey and Ferguson, 2015) where they must survive in a variety of cell types with varying immune pressures. In order to be successful in their hosts, these parasites are capable of converting to life forms that each serve an important function for survival and fitness. Although these parasites exhibit the same infectious life forms, they have fundamental differences in their life cycles and stage conversion strategies. This review will focus on the critical differences in stage conversion between tachyzoites, the rapidly replicating life form, and bradyzoites, the slower growing parasites comprising tissue cysts, in T. gondii, H. hammondi, and N. caninum.
T. gondii, H. hammondi, and N. caninum are all closely related (Figure 1A), obligate intracellular parasites that follow two-host life cycles (See detailed description in section 2). These parasites species also share the same class of organelles and have several shared genomic features. T. gondii and H. hammondi share >95% of their genomes in near perfect synteny (Walzer et al., 2013), while T. gondii and Neospora caninum genomes are >81% syntenic (Adomako-Ankomah et al., 2014). Conservative predictions have identified 7,095 shared orthologs between H. hammondi and T. gondii and 6,308 orthologs between T. gondii and N. caninum (Lorenzi et al., 2016). Despite these genetic similarities, they exhibit substantial differences in pathogenesis, host range, and life cycles.
Figure 1 Relationships between Toxoplasma gondii, Hammondia hammondi, and Neospora caninum. (A) Neighbor-joining tree depicting relationship between the ITS1 (internal transcribed spacer 1) sequences of T. gondii, H. hammondi, and N. caninum. P. falciparum is used as an outgroup. ITS1 sequences were chosen to highlight the relationship between these parasite species due to high variability often attributed to these non-coding sequences. Sequences were obtained from GenBank. Bootstrap values for 1000 replicates are indicted. Scale bar represents the substitutions per site. (B) Diagrams showing the life cycle of T. gondii, H. hammondi, and N. caninum.
Toxoplasma gondii has a broad host range and can infect all warm-blooded animals including birds (Tenter et al., 2000). T. gondii is responsible for the human disease toxoplasmosis and has infected approximately 2 billion people worldwide (Furtado et al., 2011). Although infections are often asymptomatic, T. gondii infections persist in the host in the form of tissue cysts, the life stage that contributes to chronic infection (Remington and Cavanaugh, 1965). Tissue cysts cannot be cleared by the host immune response nor can they be eliminated by known antiparasitic drugs (Tomavo and Boothroyd, 1995; Sullivan and Jeffers, 2012). T. gondii infections are thought to be long term, as bradyzoite containing tissue cysts reside in host tissue for extended periods of time and can reactivate causing clinical disease (Tenter et al., 2000; Weiss and Kim, 2000; Rougier et al., 2017). T. gondii tissue cysts can cause severe complications for immunocompromised individuals, such as HIV/AIDS and organ transplant patients, when latent infections reactivate into highly replicative life forms and result in tissue damage (Derouin et al., 1987; Derouin et al., 2008). Furthermore, bradyzoite containing tissue cysts maintained in the animal population contributes to the spread of T. gondii to both animals and humans, as T. gondii is the leading cause of death caused by a food borne illness in the United States (CDC - Toxoplasmosis; Tenter et al., 2000; Tenter, 2009). Individuals, even those who are immunocompetent, infected with T. gondii can also develop ocular toxoplasmosis. T. gondii is capable of invading and replicating in the retina which can result in severe retinal damage that can lead to blindness (Ozgonul and Besirli, 2017).
Despite being the nearest living relative of T. gondii, H. hammondi is avirulent in comparison to T. gondii. H. hammondi is not known to infect humans and is not known to cause natural disease in any animal model (Dubey and Sreekumar, 2003). H. hammondi has a restricted host range when compared to T. gondii, as its only known natural intermediate hosts are rodents (Mason, 1978), roe deer (Entzeroth and Scholtyseck, 1978), and goats (Shimura and Ito, 1987). Despite having a limited natural host range, H. hammondi has been shown to experimentally infect monkeys (Dubey and Wong, 1978), dogs (Dubey, 1975), rabbits, and pigs (Dubey and Sreekumar, 2003), yet is unable to infect birds (Wallace, 1975; Dubey and Streitel, 1976). Despite this slight expansion in experimental host range, nonmurine animals are considered poor hosts for H. hammondi as infections do not result in robust chronic infection as H. hammondi-infected tissues from these animals produce fewer oocysts compared to H. hammondi-infected tissues from murine hosts upon sexual reproduction (Dubey and Streitel, 1976).
In stark contrast to the avirulent nature of H. hammondi, N. caninum is the major cause of bovine abortion, resulting in losses of over a billion dollars worldwide in cattle industries (Dubey et al., 2007; Goodswen et al., 2013). Like with T. gondii, the formation of tissue cysts is also critical for the transmission and survival of N. caninum. The reactivation of bradyzoite-containing tissue cysts into fast replicating tachyzoites during bovine pregnancy results in efficient transmission to the fetus. Efficient transmission, persistence, and recrudescence in asymptomatic cows is a significant biotic constraint in these agriculturally important animals, and currently there is no treatment or vaccine for bovine neosporosis (Buxton et al., 2002; Dubey et al., 2006; Williams and Trees, 2006; González-Warleta et al., 2018). While cattle are considered the major intermediate host, N. caninum can also infect a number of other domestic and wild ruminant species where its infection can result in disease (Dubey et al., 2013).
Life Cycles of Toxoplasma gondii, Hammondia hammondi, and Neospora caninum
Toxoplasma gondii follows a facultative homoxenous/heteroxenous two host life cycle (Figure 1B). Sexual reproduction of T. gondii occurs in its definitive hosts which include members of the Felidae genus and produces millions of orally infectious oocysts that are environmentally stable. Each oocyst contains 8 sporozoites contained within 2 sporocysts that are surrounded by an oocyst wall (Frenkel et al., 1970; Dubey, 1998; Dubey, 2009). When oocysts are ingested by an intermediate host, the sporozoites will excyst within the host digestive system and invade the intestinal epithelium. Once in the intestinal epithelium, sporozoites differentiate into tachyzoites, which are the fast growing life stage responsible for acute infection. During a primary infection of a naïve intermediate host, T. gondii tachyzoites are capable of crossing the placenta, which can result in vertical transmission of this parasite (McAuley, 2014). Eventually, T. gondii tachyzoites differentiate into bradyzoites, the slow growing life stage associated with chronic infection. Bradyzoites are found within tissue cysts which typically reside in the central nervous system or in skeletal or cardiac muscle (Dubey et al., 1998). Bradyzoite tissue cysts are orally infectious to the definitive host. When ingested by a definitive host, tissue cysts will differentiate into the sexual stages resulting in the production of millions of oocysts, thus completing the life cycle (Dubey and Frenkel, 1972). Additionally, cats have been described as complete hosts for T. gondii because they support proliferation of tachyzoites and bradyzoites in extra-intestinal tissues in addition to supporting sexual life stages and sexual reproduction in intestinal tissues (Frenkel, 1977). One of the most critical components of the T. gondii life cycle is reactivation. Reactivation can occur when 1) a chronically infected host becomes immunocompromised which results in rapid proliferation and dissemination of tachyzoites or 2) when a naïve intermediate host ingests T. gondii tissue cysts, the bradyzoites contained within these tissue cysts are released during digestion and differentiate back to tachyzoites, which then disseminate and cause acute infection in the host before encysting during chronic infection. Reactivation results in expanded transmission for T. gondii, as it allows for the parasites to be continually propagated through asexual reproduction in intermediate hosts and underlies disease progression in immunocompromised hosts (Dubey et al., 1998). To date, the molecular determinants of this unique ability have not been elucidated, but it has likely had a dramatic impact on the global distribution and broad host range of T. gondii.
In comparison to T. gondii, Hammondia hammondi follows a strict obligate heteroxenous life cycle (Figure 1B). Sexual reproduction only occurs within the intestinal epithelium of the definitive host, which, like T. gondii, includes felids. H. hammondi oocysts, like T. gondii oocysts, are orally infectious to intermediate hosts (Frenkel and Dubey, 1975; Dubey and Ferguson, 2015). Unlike T. gondii infections, feline hosts can only support H. hammondi enteroepithelial stages and do not support extraintestinal infections (Dubey and Sreekumar, 2003). Furthermore, during asexual reproduction H. hammondi remain infectious to intermediate hosts until they terminally differentiate into tissue cyst stages (Dubey and Sreekumar, 2003; Sokol et al., 2018) that are only orally infectious to definitive feline hosts. It is hypothesized that terminally differentiated H. hammondi parasites are incapable of reactivation, however, this has yet to be tested in head-to-head comparisons with T. gondii. Furthermore, H. hammondi is not known to be capable of vertical transmission (Dubey and Streitel, 1976).
Like T. gondii, N. caninum also follows a complex facultative heteroxenous life cycle (Figure 1B). As described for T. gondii and H. hammondi, sexual reproduction for N. caninum infections in the definitive host (in this case canines rather than felines) results in oocyst production and subsequent excretion in host feces. N. caninum oocysts are environmentally stable and contain sporozoites that are orally infectious to intermediate hosts. N. caninum undergoes sexual reproduction in members of the Canis genus (Donahoe et al., 2015) and it is presumed that sexual reproduction occurs in enteroepithelial cells similar to T. gondii and H. hammondi in felid infections, however, little is known about the sexual life cycle of N. caninum infections. The first report of enteroepithelial developmental stages of N. caninum was published in 2015 and identified oocyst and schizont-like structures in epithelia in a naturally infected dog (Kul et al., 2015) N. caninum tachyzoites and bradyzoites can be found in both intermediate and definitive host tissue, primarily in the central nervous system (Dubey et al., 2002; Dubey et al., 2007). N. caninum infections in canids are similar to T. gondii in felids in that dogs can be considered complete hosts for N. caninum and support replication of all three infectious life stages. As with T. gondii, transmission via carnivory of infectious tissue cysts is important for horizontal transmission of N. caninum to the definitive host. Although experimental infections demonstrate N. caninum tissue cysts are orally infectious (Lindsay and Dubey, 1990; Lindsay et al., 2001), the ingestion of sporulated oocysts is the only known natural mode of horizontal transmission to cattle (De Marez et al., 1999; Kano et al., 2005; Eastick and Elsheikha, 2010). Vertical transmission is the most frequent mode of transmission in bovine hosts and both endogenous (reactivated) and exogenous (primary) transplacental infections occur (Williams et al., 2009). During vertical transmission, N. caninum converts into fast-replicating tachyzoites which cross the placenta to transmit to offspring often resulting in abortion. Following transmission, N. caninum converts to bradyzoites to evade the host immune responses and tissue cysts form. It is thought the interconversion from bradyzoite to tachyzoite, allows for one infected animal to transmit the parasite to offspring repeatedly. In support of this, recrudescence and transmission have been described in cattle (Williams et al., 2009), sheep (Gutiérrez-Expósito et al., 2020) and in dogs (Cole et al., 1995; Barber and Trees, 1998; Heckeroth and Tenter, 2007). As for T. gondii, the means by which N. caninum is capable of moving both forwards and backwards in its life cycle is unknown.
Regardless of parasite species, the formation of bradyzoites is a critical step in the transmission of T. gondii, H. hammondi, and N. caninum, despite clear differences in their life cycles. Bradyzoites are necessary for transmission as their cyst wall provides protection during passage through the mammalian gut (Jacobs et al., 1960), and they are also required for sexual reproduction which dramatically expands the number of infectious oocysts available to infect new hosts. Even though the definitive hosts for T. gondii and N. caninum (felines and canines, respectively), are complete hosts (host that can support both sexual and asexual replication), bradyzoite formation within these animals is still needed in order for sexual reproduction to occur. Bradyzoites also allow the parasites to remain in a host for extended period of time as they cannot be cleared by the host immune system. Finally, interconversion that occurs in T. gondii and N. caninum allows for these parasites to be transmitted completely independently of the definitive host, a remarkable trait given the vastly different species that can serve as intermediate hosts for these parasites. For these reasons, understanding the mechanisms driving the conversion of tachyzoites to bradyzoites and how it compares between species is necessary to manage the many manifestations of disease caused by these organisms. Moreover, by identifying the developmental sensors, triggers, and components in these species and comparing their activities in each may lead to a better understanding of how this process is regulated on the molecular level.
Inducers of Bradyzoite Development
While environmental signals are likely at the heart of stage conversion in T. gondii and its near relatives, the precise mechanisms used to respond to these signals have remained elusive. However, the effect of various signals on inducing life stage development, specifically tissue cyst formation, has been well studied in T. gondii. Furthermore, recent work has begun to identify distinct responses to these triggers in H. hammondi, indicating the presence of a divergent stress response in this species.
Toxoplasma gondii
Bradyzoite formation in T. gondii has been extensively studied. An important, but underappreciated, fact is that most strains of T. gondii are capable of spontaneously converting into bradyzoites when grown in vitro in a variety of different host cells (Lindsay et al., 1991; Lindsay et al., 1993). When T. gondii infections are initiated with parasites derived from sporozoites or from tachyzoites or bradyzoites that have not be extensively passaged following isolation, the parasites will first grow as tachyzoites but will later form tissue cysts that express bradyzoite markers and/or are able to induce oocyst shedding when fed to cats (Lindsay et al., 1991; Jerome et al., 1998). This phenomenon of spontaneous stage conversion in T. gondii was most thoroughly studied in T. gondii strain VEG. When infections are initiated with T. gondii VEG sporozoites, the parasites differentiate into a rapidly growing tachyzoite stage resembling many lab-adapted strains like T. gondii RH, and after ~20 divisions they begin to differentiate into slower growing parasites that express bradyzoite markers, suggesting that there may be a developmental clock controlling this spontaneous conversion (Jerome et al., 1998). Taken together, these findings suggest that there is some type of parasite intrinsic factor that enables these parasites to transition to bradyzoites following initial tachyzoite expansion.
Host factors, specifically the differentiation state of a given host cell, can also impact T. gondii cystogenesis. T. gondii forms tissue cysts when grown in mouse primary skeletal muscle cells that have been differentiated into polynucleated myotubes, which are withdrawn from cell cycle progression (Ferreira-da-Silva et al., 2009; Swierzy and Lüder, 2015). When these host cells are genetically manipulated to knock-down Testis-specific Y-encoded-like protein 2 (Tspyl2), a negative cell cycle regulator that contributes withdraw from host cell cycle progression in these myotubes, T. gondii fails to form tissue cysts in these cells (Swierzy and Lüder, 2015). Additionally, expression levels of the host gene human cell division autoantigen-1 (CDA1) are important for bradyzoite development. T. gondii has been shown to grow slower and express bradyzoite specific genes when grown in host cells treated (pre-treatment or continuous treatment) with the trisubstituted pyrrole small molecule Compound 1, which upregulates expression of host CDA1 (Radke et al., 2006). CDA1 is a negative regulator of cell growth and has regions with homology to testis protein TSPY (Chai et al., 2001). Additionally, T. gondii forms tissue cysts when grown in HeLa cells that overexpress a transgene encoding CDA1 (Radke et al., 2006). The ability of cells that have withdrawn from their cell cycle to promote tissue cyst formation in T. gondii is a likely contributor to the preference T. gondii shows for muscular tissue and the tissues of the central nervous system.
Several well characterized stressors are known to induce T. gondii tachyzoite-to-bradyzoite stage conversion in vitro (summarized in Table 1). Perhaps the most well-known stressor that leads to robust formation of T. gondii tissue cysts in vitro is alkaline pH (pH ~8 as compared to the standard pH growth conditions of 7.2–7.4). Multiple groups have shown that alkaline pH induces T. gondii cyst development either when applied to host cells after infection (Soête et al., 1994) or when applied to extracellular parasites prior to infection (Weiss et al., 1998). Despite robust induction of T. gondii tissue cyst development, the exact mechanism remains unknown. It is possible that alkaline pH derived stress induces a myriad of both host and parasite derived signals that are needed in order to initiate bradyzoite development in T. gondii. Furthermore, treatment of infected host cells with pH 6.8 media has also been shown to induce bradyzoite development (Weiss et al., 1995). In addition to changes in pH, heat shock (43°C as opposed to 37°C) and sodium arsenite treatment of infected host cells have also been shown to induce stage conversion in T. gondii, however heat shock is not an optimal method for inducing bradyzoite development as it often results in decreased parasite invasion, parasite killing, and loss of host cell viability (Soête et al., 1994). Nutrient starvation can also induce stage conversion in T. gondii. Pyrimidine starvation achieved via deletion of the uracil phosphoribosyl transferase (UPRT) gene in combination with growth in atmospheric CO2 (0.03% compared to 5%) also leads to a parasite growth reduction and expression of bradyzoite markers (Bohne and Roos, 1997). Arginine starvation also decreases the replication of T. gondii and induces tissue cyst formation (Fox et al., 2004). Cholesterol depletion via growth in media supplemented with lipoprotein depleted serum (as compared to growth in 5% fetal bovine serum) has also been shown to induce bradyzoite gene expression (Ihara and Nishikawa, 2014). Additionally, interferon gamma (IFN-γ) treatment of T. gondii infected macrophages results in expression of bradyzoite specific antigens (Bohne et al., 1994), however IFN-γ is not capable of inducing expression of bradyzoite specific antigens in human fibroblasts (Suzuki et al., 1989; Bohne et al., 1993; Soête et al., 1994; Weiss et al., 1995). Other in vitro stressors that may mimic IFN-γ-driven immune pressure also induces T. gondii cystogenesis, such as the production of nitric oxide. Exogeneous nitric oxide produced from sodium nitroprusside (SNP) treatment can induce bradyzoite development (Bohne et al., 1994). Exogenous nitric oxide likely inhibits proteins involved in the electron transport chain, thus treatment with mitochondrial inhibitors oligomycin, antimycin A, (Bohne et al., 1994), and atovaquone (Tomavo and Boothroyd, 1995) can also induce expression of bradyzoite antigens in T. gondii. Overall, the numerous and diverse exogenous stressors capable of inducing bradyzoite development in T. gondii suggest that multiple signals can be used as triggers to induce the fundamental process of bradyzoite formation.
In comparison to in vitro systems, in vivo factors that induce cystogenesis are much less clear. Tumor necrosis factor-alpha (TNF-α) and inducible nitric oxide synthase (iNOS) may play a role in restricting cystogenesis, as TNF receptor p55- and p75-deficient mice and iNOS deficient mice develop more tissue cysts in the brain compared to wild type mice despite relatively equivalent parasite burden in peritoneal cells early in infection. Interestingly, mice deficient for TNF-α receptors or iNOS succumb to chronic infection while the WT parasites survive (Scharton-Kersten et al., 1997; Yap et al., 1998). It is challenging to determine if the increase in tissue cysts in the brains of these mice is a result of TNF-α and iNOS restricting tissue cyst development, or if more parasites make it to the brain prior to tissue cyst formation. Future experiments using live imaging that quantifies parasite burden could be useful to test these hypotheses. Additionally, CD4+ and CD8+ T-cells are important for the maintenance of chronic infection characterized by the bradyzoite/tissue cyst life stage. Depletion of these cells with neutralizing antibodies leads to reactivation of T. gondii infection leading to parasite proliferation (Gazzinelli et al., 1992). It is also thought that IFN-γ may play a critical role in cystogenesis. It is hypothesized that IFN-γ contributes to the initiation of tissue cyst formation in vivo, as it can induce cystogenesis in vitro (described above), however IFN-γ knockout mice fail to control acute proliferation of parasites and succumb to acute infection (Suzuki et al., 1988; Suzuki et al., 1989) even when infected with avirulent strains of T. gondii (Coombs et al., 2020) making it difficult to determine if IFN-γ induces cystogenesis in vivo. It is also possible that T. gondii spontaneously forms tissue cysts during in vivo infections, however this spontaneous development is again challenging to observe experimentally due to the lethality of T. gondii infections in mice with disrupted immune systems. Linking what is known about in vitro cyst development in T. gondii to what happens in vivo is a significant, but important, knowledge gap in the field that will require new technological innovation to fill.
Hammondia hammondi
In comparison to T. gondii, little is known about bradyzoite and tissue cyst formation in H. hammondi. When grown in vitro, H. hammondi fails to grow in continuous culture and spontaneously undergoes a terminal differentiation process where it completely converts to tissue cysts that are only infectious to definitive feline hosts (Sheffield et al., 1976; Riahi et al., 1995; Dubey and Sreekumar, 2003; Sokol et al., 2018). The timing of tissue cyst formation corresponds to when H. hammondi parasites lose their ability to infect a new host cell (Sokol et al., 2018), demonstrating that H. hammondi follows a strict obligate heteroxenous life cycle even in in vitro growth conditions (a sharp contrast to both T. gondii and N. caninum). Furthermore, comparative transcriptomic analysis between replicating T. gondii and H. hammondi showed that the H. hammondi transcriptional profile is enriched for genes that are typically reserved for expression during bradyzoite and sexual stages occurring in feline intestinal cells in T. gondii (Sokol et al., 2018). It is likely that H. hammondi follows a strictly regulated life cycle where it is poised to convert to its next life stages after a pre-defined time as a given life form.
Even though H. hammondi completely and spontaneously forms tissue cysts when grown in vitro, it cannot be induced to form tissue cysts with alkaline pH, a robust inducer of stage conversion in T. gondii, at early time points following sporozoite-initiated infection (Sokol et al., 2018). This discovery was important because it suggested that the ability to constitutively respond to alkaline pH in T. gondii was a derived trait. Since this initial work we have also investigated if H. hammondi is eventually able to form tissue cysts in response to alkaline pH derived stress applied at later stages in its in vitro cycle. Interestingly, we have found that when alkaline pH derived stress is applied for 48 h at later developmental time points (Day 13 post sporozoite-derived infection), significantly more tissue cysts form in response to alkaline pH treatment than occur spontaneously at this time (Figure 2). This finding suggests that as H. hammondi progresses through a predefined developmental program it differentiates from a life form that is incapable of responding to alkaline pH (unable to sense and/or respond) to a life form that is capable of sensing and/or responding. This hints at a conserved linkage between alkaline pH responsiveness and the tachyzoite to bradyzoite stage conversion. Future work investigating the differences in gene expression between these time points could be promising in uncovering additional components of the mechanisms that these parasites use to sense and respond to their environment. It is currently unknown as to how H. hammondi responds to other stressors known to induce tissue cyst development in T. gondii.
Figure 2 H. hammondi can respond to stress conditions when exposed to alkaline pH 13 days post excystation (DPE) from oocysts. (A) Percentage of DBA positive vacuoles observed following 48 h of alkaline pH stress initially applied at D4, 5, 7, 13, and 15PE for T. gondii VEG. (B) Percentage of DBA positive vacuoles observed following 48 h of alkaline pH stress initially applied at D4, 5, 7, 13, and 15PE for H. hammondi American. Statistical significance was determined by 2way ANOVA with Sidak’s multiple comparisons test of arcsine transformed data. (N = 2–3 biological replicates, *P = 0.03, **P < 0.01, ***P < 0.001, and ****P < 0.0001) This experiment, with the exception of time of alkaline stress application at the time points mentioned above, was performed as previously described (Sokol et al., 2018).
Neospora caninum
Like T. gondii, N. caninum alternates between two life stages presumably to survive host immune responses. The mechanisms underlying N. caninum tachyzoite to bradyzoite conversion remain largely unknown (to an even greater extent than for H. hammondi) due to difficulties in developing in vitro models for bradyzoite development. Methods used to obtain T. gondii bradyzoites in vitro are ineffective or inefficient for N. caninum cyst formation. Although nitric oxide treatment of murine keratinocytes infected with N. caninum tachyzoites yields cysts, they are surrounded by thick keratin filament bundles and thus impede parasite purification processes (Vonlaufen et al., 2002). Very few studies have investigated the effects of stress on stage conversion for N. caninum. One study suggests that nitric oxide, increasing pH, or increasing temperature can increase tachyzoite to bradyzoite conversion in N. caninum (Weiss et al., 1999). SNP has also been shown to increase expression of N. caninum bradyzoite and cyst wall markers (Risco-Castillo et al., 2004). However, there are no studies investigating any difference in gene expression during the tachyzoite to bradyzoite conversion process in N. caninum. Substantial work with regards to how to identify N. caninum bradyzoites and reliably produce this life stage in vitro and in vivo is still needed in order to expand our understanding of how stage conversion occurs in N. caninum.
Parasite Intrinsic Molecular Mechanisms of Stage Conversion
Chromatin
Stage conversion in eukaryotic parasites is accompanied by significant changes in patterns of gene expression (Gomez et al., 2010; Chen et al., 2018). The chromatin landscape of a given life stage plays a large role in what genes are expressed, therefore playing a critical role in stage conversion. Several chromatin remodeling factors have been identified in T. gondii that play a role in altering the chromatin landscape during different life stages. One such factor is Histone Deacetylase 3 (HDAC3), which is a component of T. gondii’s corepressor complex. HDAC3 is associated with bradyzoite specific promoters (Saksouk et al., 2005) and when its activity is inhibited with the compound FR235222, expression of bradyzoite genes increases (Bougdour et al., 2009). These findings suggest that histone deacetylation via HDAC3 functions to repress the expression of bradyzoite genes and keep T. gondii in a tachyzoite life form. HDAC3 has been shown to work with the recently discovered T. gondii microrchidia (MORC) protein. MORC interacts with several AP2 transcription factors (Farhat et al., 2020) [including AP2IX-4 and AP2XII-2 discussed below (Srivastava et al., 2020)] and recruits HDAC3 to chromatin, enabling the generation of hypo-acetylated chromatin which represses gene expression. When MORC is depleted in T. gondii, the parasites begin to express transcripts typically expressed in other life stages, such as merozoite and oocysts specific genes, that are restricted to the T. gondii sexual stages (Farhat et al., 2020). These findings suggest that MORC functions as a repressor of sexual development associated gene expression through chromatin modification in T. gondii. Our transcriptional data from replicating H. hammondi on Day 4 (D4) and Day 15 (D15) post sporozoite infection, does not show any changes in transcriptional abundance of either of H. hammondi’s orthologs of HDAC3 or MORC (Figure 3). However, in comparison to T. gondii, H. hammondi’s transcriptional profile is enriched for genes that are associated with sexual development in T. gondii (Sokol et al., 2018), a process which has been shown to be repressed by MORC (Farhat et al., 2020). Because of this similarity, we hypothesized that transcript abundance of MORC repressed genes would be enriched in H. hammondi at D15 compared to D4. To test this hypothesis, we conducted pre-ranked gene set enrichment analysis (GSEA) as previously described (Subramanian et al., 2005) and found significant enrichment for MORC repressed transcripts [gene sets derived from data published in (Farhat et al., 2020)] (NES= -10.88, FDRq = ~0.00 ) in D15 H. hammondi (Figure 4). This analysis suggests that transcriptional changes in spontaneously developing H. hammondi resemble some of the transcriptional changes observed in MORC depleted T. gondii. It would be interesting to further investigate if altering MORC levels could alter H. hammondi’s terminal differentiation phenotype.
Figure 3 Heatmap representing H. hammondi transcriptional abundance during spontaneous development of known regulators of bradyzoite formation. Heatmaps show mean centered Log2FPM values. Asterisk (*) represent genes with significant differences between D4 (N = 2 biological replicates) and D15 (N = 3 biological replicates) samples. Significance is defined as |Log2 Fold Change| >1 and Padj < 0.01. T. gondii gene IDs for these genes and the gene IDs for each orthologs in H. hammondi and N. caninum are found in Table 2. The H. hammondi transcriptional data used to generate this figure was obtained from (Sokol et al., 2018).
Figure 4 Spontaneously developing H. hammondi transcriptional abundance is enriched for genes regulated by MORC. Preranked GSEA, comparing D4 and D15 HhEth1, ranked listed was calculated from Log2 fold change between D4 and D15 spontaneous developing HhEth1 samples. The data used to generate this figure was obtained from (Sokol et al., 2018). Gene sets were created with data from (Farhat et al., 2020).
Another histone remodeling enzyme found in T. gondii is GCN5-A, a lysine histone acetyltransferase. This enzyme plays an oppositional role to HDAC3. GCN5-A is found at tachyzoite promoters when T. gondii is grown under tachyzoite growth conditions (Saksouk et al., 2005). Additionally, ChIP qPCR experiments have shown that when T. gondii is exposed to alkaline pH stress conditions, GCN5-A occupancy is enriched in the promotors of bradyzoite specific genes that are upregulated in response to stress. When GCN5-A is knocked out in T. gondii, the parasites are unable to upregulate 74% of known bradyzoite genes in response to alkaline pH induced stress (Naguleswaran et al., 2010). Together, these findings demonstrate that GCN5-A plays a critical role in T. gondii’s ability to alter its gene expression in response to alkaline pH stress.
Additional chromatin remodeling enzymes that play a role in the alteration of stage conversion associated gene expression have also been identified in T. gondii. These include TgCARM1 (Saksouk et al., 2005), TgSCRAP (Sullivan et al., 2003), and TgRSC8 (Craver et al., 2010; Rooney et al., 2011). TgCARM1 is a histone arginine methyltransferase protein that is essential for parasite replication. When N-methyltransferase activity is inhibited with the small molecule AMI-1 via pretreatment of extracellular parasites, T. gondii forms significantly more bradyzoites compared to a vehicle control (Saksouk et al., 2005). TgSCRAP, a Snf2-related CBP activator protein and SNF/SWI chromatin remodeler, upregulates the expression of the known bradyzoite gene bradyzoite antigen 1 (BAG1) during alkaline pH induced stress, and has been shown to enhance CREB (cAMP response element binding protein) mediated transcription, which may suggest a role in the protein kinase A signaling pathway that has also been implicated in bradyzoite development for T. gondii (Sullivan et al., 2003). Another chromatin remodeling complex that contributes to bradyzoite development is TgRSC8, a homolog of the nucleosome remodeling complex Rsc8p protein in Saccharomyces cerevisiae. When this protein is mutated in T. gondii, some bradyzoite genes showed a significant reduction in transcript abundance when exposed to alkaline pH stress conditions. However, these mutants did not show reduced Dolichos biflorus agglutinin (DBA) staining (Rooney et al., 2011), which specifically recognizes the glycosylated cyst wall protein CST1 (Zhang et al., 2001). In addition to chromatin remodelers, histone variants have also been implicated in stage conversion in T. gondii. The histone variant H2A.Z is expressed in mature, in vivo bradyzoites and H2AX is also expressed in mature, in vivo bradyzoites but also displays increased expression in vitro during alkaline pH stress (Dalmasso et al., 2009). All together, these findings suggest that the alteration of chromatin is an important contributor to stage conversion associated gene expression in T. gondii.
Despite having orthologs of all of these chromatin remodeling enzymes and histone variants, our understanding of their role in bradyzoite formation in H. hammondi and N. caninum is mostly unclear. Our transcriptional data from replicating H. hammondi show no significant changes in the transcript abundance for any of the H. hammondi orthologs during spontaneous development (Figure 3). However, these findings could suggest that transcriptional abundance of these genes is needed similarly in all life stages and that the mechanisms controlling their translation, activation, or their recruitment to specific genes are important for initiating the tachyzoite to bradyzoite developmental transitions.
Transcription Factors
Transcription factors are an important class of proteins that play a significant role in the control of stage conversion specific gene expression and have long been investigated for their role in stage conversion associated gene expression in T. gondii. One of the first major classes of transcription factors investigated for their role in stage conversion in T. gondii were the AP2 transcription factors. AP2 factors were first identified in Apicomplexans in 2005. These transcription factors share the Apetala2 (AP2) integrase DNA binding domain typically found in transcription factors of numerous plant species (Balaji et al., 2005). AP2 transcription factors are known to play a major role in stage conversion in Plasmodium species (Painter et al., 2011). There are currently 67 AP2 factors (66 annotated as AP2 domain transcription factors and 1 annotated as an AP2 domain-containing protein) in the T. gondii ME49 genome (Gajria et al., 2008). However, only 6 of these AP2 transcription factors have been tied to bradyzoite development in T. gondii. The AP2 transcription factor AP2IX-9 functions mainly as a repressor of bradyzoite development, maintaining parasites in an intermediate, pre-bradyzoite state. AP2IX-9 binds to the CAGTGT motif and functions to repress transcription (Radke et al., 2013). Furthermore, deletion of AP2IX-9 results in increased tissue cyst formation in parasites cultivated in normal growth conditions (Hong et al., 2017). During spontaneous development (D4 versus D15) in H. hammondi, we see significant increases in transcriptional abundance of the H. hammondi ortholog of AP2IX-9 (|Log2 Fold Change| = 2.21, Padj = 0.009). Since AP2IX-9 is known to keep parasites in a pre-bradyzoite state, this data could indicate that D15 H. hammondi are being maintained in a pre-bradyzoite like state, prior to their complete terminal differentiation which is first observed at D23 post sporozoite derived infection (Sokol et al., 2018). Another AP2 factor, AP2XII-2, has been shown to interact with the MORC protein and results in increased tissue cyst formation in vitro upon knockdown in T. gondii, suggesting that this factor may be important for maintaining tachyzoites (Srivastava et al., 2020). Additionally, AP2 transcription factors have been identified in T. gondii that are involved in promoting bradyzoite development. These include AP2IV-4 (Radke et al., 2018), AP2IV-3 (Hong et al., 2017), AP2IX-4 (Huang et al., 2017), and AP2XI-4 (Walker et al., 2013). When these AP2 transcription factors are deleted, parasites have a decreased ability to form tissue cysts in vitro and/or in vivo. Furthermore, alteration (either deletion or overexpression) of these factors results in significant differences in transcript abundance of known bradyzoite genes (Walker et al., 2013; Hong et al., 2017; Huang et al., 2017; Radke et al., 2018). Our H. hammondi transcriptional data does not show any significant differences in transcript abundance in these AP2 factors during spontaneous development in H. hammondi (Figure 3).
In addition to AP2 transcription factors, T. gondii has additional transcription factors that are critical for stage conversion. One such transcription factor is Bradyzoite Formation Deficient 1 (BFD1). BFD1 was recently identified as a master transcriptional regulator of bradyzoite development in T. gondii using a large-scale genetic screen. BFD1 is a nuclear localized Myb-like DNA binding protein that binds to the CACTGG motif near that transcriptional start site of differentially regulated genes. When BFD1 is deleted in T. gondii, these parasites fail to form tissue cysts in vitro in response to alkaline pH derived stress and treatment with Compound 1. These knockout parasites also fail to form tissue cysts in vivo. Furthermore, BFD1 knockout parasites fail to express several bradyzoite specific genes when treated with alkaline pH, suggesting that BFD1 plays a major role in initiating stage conversion associated gene expression (Waldman et al., 2020). Transcriptional abundance of the H. hammondi ortholog of BFD1 is modestly but significantly upregulated (|Log2 Fold Change| = 1.47, Padj = <0.001) during spontaneous development (Figure 3), suggesting that increases in BFD1 expression in H. hammondi may play an important role in H. hammondi’s terminal differentiation phenotype.
Additional T. gondii proteins that may play a role in stage conversion are the glycolytic enzymes, Enolase1 (ENO1) and Enolase 2 (ENO2). ENO1 is specifically expressed in bradyzoites and is a known bradyzoite specific gene. ENO2 is expressed in tachyzoites and can be found localized in the cytoplasm and nucleus (Ferguson et al., 2002). When ENO1 is deleted in T. gondii, the ability of the parasite to form in vivo cysts is impaired. Both ENO1 and ENO2 have been shown to bind promoters in ChIPseq and ChIP qPCR experiments and ENO1 has been shown to bind the ENO2 promoter. Furthermore, analysis of the ENO1 promoter revealed a stress response element that could be activated with nuclear extracts purified from bradyzoites (Kibe et al., 2005). Together, this data demonstrates a role as transcription factors implicated in stage conversion for ENO1 and ENO2. ENO1 is significantly upregulated during spontaneous development in H. hammondi (Figure 3), however it is possible that this increase could also be due to ENO1’s metabolic role for bradyzoites.
RNA-Binding Proteins
While stage conversion is typically accompanied by global changes in transcript abundance in Apicomplexan parasites, translation control is an additional component needed for stage conversion associated gene expression. Several RNA binding proteins have been identified in T. gondii and some have been implicated in the conversion between tachyzoites and bradyzoites. Such factors include TgIF2α/eIF2 (eukaryotic initiation factor 2 alpha) and TgIF2K-A (initiation factor 2 kinase -A). TgIF2K-A is responsible for phosphorylating and activating TgIF2α, which functions as an inhibitor of translation initiation. TgIF2α is phosphorylated in response to stress derived from both alkaline pH and heat shock (Sullivan et al., 2004). TgIF2α phosphorylation is maintained in bradyzoites. When dephosphorylation of TgIF2α is inhibited, parasites both increase the transcriptional abundance of known bradyzoites genes and form DBA positive tissue cysts (Narasimhan et al., 2008). Furthermore, when the activity of TgIF2K-A is inhibited in T. gondii, thus preventing TgIF2α phosphorylation, these parasites form significantly fewer tissue cysts when exposed to alkaline pH stress (Augusto et al., 2018). Our transcriptional data from replicating H. hammondi shows that transcript abundance of HhIF2K-A is significantly upregulated during spontaneous development ((|Log2 Fold Change| = 1.22, Padj = <0.001) (Figure 3) (Sokol et al., 2018). This increase in transcriptional abundance could correlate to increased IF2α phosphorylation and translational inhibition in H. hammondi. Additional experiments investigating HhIF2α phosphorylation and HhIF2K-A activity during bradyzoite formation in H. hammondi would be helpful in identifying translation control as a conserved mechanism of stage conversion.
Additionally, T. gondii encodes two RNA binding proteins related to Alba proteins in archaea, TgAlba1 and TgAlba2. In response to alkaline pH derived stress, both TgAlba1 and TgAlba2 colocalize with RNA granules. These proteins bind greater than 30 RNAs, including their own. TgAlba1 binds to the promoter of TgAlba2. Upon deletion of TgAlba1, TgAlba2 is no longer translated. Furthermore, deletion of TgAlba1 in T. gondii also leads to decreased tissue cyst formation in vitro (in response to alkaline pH stress) and in vivo (Gissot et al., 2013). However, we do not see significant changes in transcriptional abundance in the H. hammondi orthologs of TgAlba1 and TgAlba2 (Figure 3). Together, these examples of RNA binding proteins found in T. gondii demonstrate that translational control plays a critical role in stage conversion associated gene expression.
Conclusions
The tachyzoite to bradyzoite transition is a fundamental developmental process for the success of T. gondii and its closest relatives H. hammondi and N. caninum, as it is necessary for the survival and transmission of these parasite species. Some similarities in exogenous stressors that induce bradyzoite formation exist between species, indicating that there is some conservation in the way that these parasites sense stress. Moreover, the genetic components involved in the mechanisms governing stage conversion between tachyzoite and bradyzoite life stages are only starting to be uncovered for T. gondii, but so far include several factors that are needed for both transcriptional and translational control. Both H. hammondi and N. caninum have syntenic orthologs of all of these genetic components identified in T. gondii (summarized in Table 2), suggesting that they may also play a role in stage conversion in these species as well. However, only a few of these genes have altered transcriptional abundance in spontaneously differentiating H. hammondi. These observations from H. hammondi suggest that the mechanisms controlling stage conversion may function differently in H. hammondi and may rely on more than transcriptional regulation alone in order to induce bradyzoite development, which is not surprising given the importance of the tachyzoite to bradyzoite transition and the complexity of stage conversion associated gene expression. Together, these studies indicate that future work aimed at linking these factors in gene regulatory networks, in addition to identifying new factors, is needed to contribute to a better understanding of how these parasites initiate the global changes in stage conversion associated gene expression on a mechanistic level.
Author Contributions
SS-B, RC, and JB conceptualized, wrote, and edited this manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by grants F31AI140529 to SS-B and R01AI116855 to JB.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Adomako-Ankomah Y., Wier G. M., Borges A. L., Wand H. E., Boyle J. P. (2014). Differential locus expansion distinguishes Toxoplasmatinae species and closely related strains of Toxoplasma gondii. MBio 5, e01003–e01013. doi: 10.1128/mBio.01003-13
Augusto L., Martynowicz J., Staschke K. A., Wek R. C., Sullivan W. J. (2018). Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii. Antimicrob. Agents Chemother. 62 (11), e01442-18. doi: 10.1128/AAC.01442-18
Balaji S., Babu M. M., Iyer L. M., Aravind L. (2005). Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains. Nucleic Acids Res. 33, 3994–4006. doi: 10.1093/nar/gki709
Barber J. S., Trees A. J. (1998). Naturally occurring vertical transmission of Neospora caninum in dogs. Int. J. Parasitol. 28, 57–64. doi: 10.1016/s0020-7519(97)00171-9
Bohne W., Heesemann J., Gross U. (1993). Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect. Immun. 61, 1141–1145. doi: 10.1128/IAI.61.3.1141-1145.1993
Bohne W., Heesemann J., Gross U. (1994). Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect. Immun. 62, 1761–1767. doi: 10.1128/IAI.62.5.1761-1767.1994
Bohne W., Roos D. S. (1997). Stage-specific expression of a selectable marker in Toxoplasma gondii permits selective inhibition of either tachyzoites or bradyzoites. Mol. Biochem. Parasitol. 88, 115–126. doi: 10.1016/s0166-6851(97)00087-x
Bougdour A., Maubon D., Baldacci P., Ortet P., Bastien O., Bouillon A., et al. (2009). Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites. J. Exp. Med. 206, 953–966. doi: 10.1084/jem.20082826
Buxton D., McAllister M. M., Dubey J. P. (2002). The comparative pathogenesis of neosporosis. Trends Parasitol. 18, 546–552. doi: 10.1016/s1471-4922(02)02414-5
CDC - Toxoplasmosis. Available at: https://www.cdc.gov/parasites/toxoplasmosis/index.html (Accessed December 3, 2018).
Chai Z., Sarcevic B., Mawson A., Toh B. H. (2001). SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J. Biol. Chem. 276, 33665–33674. doi: 10.1074/jbc.M007681200
Chen L.-F., Han X.-L., Li F.-X., Yao Y.-Y., Fang J.-P., Liu X.-J., et al. (2018). Comparative studies of Toxoplasma gondii transcriptomes: insights into stage conversion based on gene expression profiling and alternative splicing. Parasitol. Vectors 11, 402. doi: 10.1186/s13071-018-2983-5
Cole R. A., Lindsay D. S., Blagburn B. L., Sorjonen D. C., Dubey J. P. (1995). Vertical transmission of Neospora caninum in dogs. J. Parasitol. 81, 208–211. doi: 10.2307/3283921
Coombs R. S., Blank M. L., English E. D., Adomako-Ankomah Y., Urama I.-C. S., Martin A. T., et al. (2020). Immediate interferon gamma induction determines murine host compatibility differences between Toxoplasma gondii and Neospora caninum. Infect. Immun. 8 (4), e00027–20. doi: 10.1128/IAI.00027-20
Craver M. P. J., Rooney P. J., Knoll L. J. (2010). Isolation of Toxoplasma gondii development mutants identifies a potential proteophosphogylcan that enhances cyst wall formation. Mol. Biochem. Parasitol. 169, 120–123. doi: 10.1016/j.molbiopara.2009.10.006
Dalmasso M. C., Onyango D. O., Naguleswaran A., Sullivan W. J., Angel S. O. (2009). Toxoplasma H2A variants reveal novel insights into nucleosome composition and functions for this histone family. J. Mol. Biol. 392, 33–47. doi: 10.1016/j.jmb.2009.07.017
De Marez T., Liddell S., Dubey J. P., Jenkins M. C., Gasbarre L. (1999). Oral infection of calves with Neospora caninum oocysts from dogs: humoral and cellular immune responses. Int. J. Parasitol. 29, 1647–1657. doi: 10.1016/s0020-7519(99)00154-x
Derouin F., Vittecoq D., Beauvais B., Bussel A. (1987). Toxoplasma parasitaemia associated with serological reactivation of chronic toxoplasmosis in a patient with the acquired immunodeficiency syndrome. J. Infect. 14, 189–190. doi: 10.1016/S0163-4453(87)92152-9
Derouin F., Pelloux H., ESCMID Study Group on Clinical Parasitology (2008). Prevention of toxoplasmosis in transplant patients. Clin. Microbiol. Infect. 14, 1089–1101. doi: 10.1111/j.1469-0691.2008.02091.x
Donahoe S. L., Lindsay S. A., Krockenberger M., Phalen D., Šlapeta J. (2015). A review of neosporosis and pathologic findings of Neospora caninum infection in wildlife. Int. J. Parasitol Parasites Wildl 4, 216–238. doi: 10.1016/j.ijppaw.2015.04.002
Dubey J. P., Lindsay D. S., Speer C. A. (1998). Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11, 267–299. doi: 10.1128/CMR.11.2.267
Dubey J. P., Barr B. C., Barta J. R., Bjerkås I., Björkman C., Blagburn B. L., et al. (2002). Redescription of Neospora caninum and its differentiation from related coccidia. Int. J. Parasitol. 32, 929–946. doi: 10.1016/s0020-7519(02)00094-2
Dubey J. P., Buxton D., Wouda W. (2006). Pathogenesis of bovine neosporosis. J. Comp. Pathol. 134, 267–289. doi: 10.1016/j.jcpa.2005.11.004
Dubey J. P., Schares G., Ortega-Mora L. M. (2007). Epidemiology and control of neosporosis and Neospora caninum. Clin. Microbiol. Rev. 20, 323–367. doi: 10.1128/CMR.00031-06
Dubey J. P., Jenkins M. C., Kwok O. C. H., Ferreira L. R., Choudhary S., Verma S. K., et al. (2013). Congenital transmission of Neospora caninum in white-tailed deer (Odocoileus virginianus). Vet. Parasitol. 196, 519–522. doi: 10.1016/j.vetpar.2013.03.004
Dubey J. P. (1975). Experimental hammondia hammondi infection in dogs. Br. Vet. J. 131, 741–743. doi: 10.1016/S0007-1935(17)35147-3
Dubey J. P. (1998). Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 28, 1019–1024. doi: 10.1016/S0020-7519(98)00023-X
Dubey J. P. (2009). History of the discovery of the life cycle of Toxoplasma gondii. Int. J. Parasitol. 39, 877–882. doi: 10.1016/j.ijpara.2009.01.005
Dubey J. P., Ferguson D. J. P. (2015). Life Cycle of Hammondia hammondi (Apicomplexa: Sarcocystidae) in Cats. J. Eukaryot. Microbiol. 62, 346–352. doi: 10.1111/jeu.12188
Dubey J. P., Frenkel J. K. (1972). Cyst-Induced Toxoplasmosis in Cats*. J. Protozool. 19, 155–177. doi: 10.1111/j.1550-7408.1972.tb03431.x
Dubey J. P., Sreekumar C. (2003). Redescription of Hammondia hammondi and its differentiation from Toxoplasma gondii. Int. J. Parasitol. 33, 1437–1453. doi: 10.1016/S0020-7519(03)00141-3
Dubey J. P., Streitel R. H. (1976). Further Studies on the Transmission of Hammondia hammondi in Cats. J. Parasitol. 62, 548. doi: 10.2307/3279410
Dubey J. P., Wong M. (1978). Experimental Hammondia hammondi infection in monkeys. J. Parasitol. 64, 551–552. doi: 10.2307/3279809
Duszynski D. W., Kvičerová J., Seville R. S. (2018). “Sarcocystidae,” in The biology and identification of the coccidia (apicomplexa) of carnivores of the world (United Kingdom: Elsevier), 331–407. doi: 10.1016/B978-0-12-811349-3.00016-5
Eastick F. A., Elsheikha H. M. (2010). Stress-driven stage transformation of Neospora caninum. Parasitol. Res. 106, 1009–1014. doi: 10.1007/s00436-010-1788-z
Entzeroth R., Scholtyseck E. (1978). The roe deer intermediate host of different Coccidia. Naturwissenschaften 65, 395. doi: 10.1007/BF00439714
Farhat D. C., Swale C., Dard C., Cannella D., Ortet P., Barakat M., et al. (2020). A MORC-driven transcriptional switch controls Toxoplasma developmental trajectories and sexual commitment. Nat. Microbiol. 5, 570–583. doi: 10.1038/s41564-020-0674-4
Ferguson D. J. P., Parmley S. F., Tomavo S. (2002). Evidence for nuclear localisation of two stage-specific isoenzymes of enolase in Toxoplasma gondii correlates with active parasite replication. Int. J. Parasitol. 32, 1399–1410. doi: 10.1016/s0020-7519(02)00129-7
Ferreira-da-Silva M., da F., Takács A. C., Barbosa H. S., Gross U., Lüder C. G. K. (2009). Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts. Int. J. Med. Microbiol. 299, 381–388. doi: 10.1016/j.ijmm.2008.10.002
Fox B. A., Gigley J. P., Bzik D. J. (2004). Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. Int. J. Parasitol. 34, 323–331. doi: 10.1016/j.ijpara.2003.12.001
Frenkel J. K., Dubey J. P., Miller N. L. (1970). Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science 167, 893–896. doi: 10.1126/science.167.3919.893
Frenkel J. K. (1977). Besnoitia wallacei of Cats and Rodents: With a Reclassification of Other Cyst-Forming Isosporoid Coccidia. J. Parasitol. 63, 611. doi: 10.2307/3279560
Frenkel J. K., Dubey J. P. (1975). Hammondia hammondi gen. nov., sp.nov., from domestic cats, a new coccidian related to Toxoplasma and Sarcocystis. Z. Parasitenkd. 46, 3–12. doi: 10.1007/BF00383662
Furtado J. M., Smith J. R., Belfort R., Gattey D., Winthrop K. L. (2011). Toxoplasmosis: a global threat. J. Glob. Infect. Dis. 3, 281–284. doi: 10.4103/0974-777X.83536
Gajria B., Bahl A., Brestelli J., Dommer J., Fischer S., Gao X., et al. (2008). ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic Acids Res. 36, D553–D556. doi: 10.1093/nar/gkm981
Gazzinelli R., Xu Y., Hieny S., Cheever A., Sher A. (1992). Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivace chronich infection with Toxoplasma gondii. J. Immunol 149, 175–180.
Gissot M., Walker R., Delhaye S., Alayi T. D., Huot L., Hot D., et al. (2013). Toxoplasma gondii Alba proteins are involved in translational control of gene expression. J. Mol. Biol. 425, 1287–1301. doi: 10.1016/j.jmb.2013.01.039
Gomez C., Esther Ramirez M., Calixto-Galvez M., Medel O., Rodríguez M. A. (2010). Regulation of gene expression in protozoa parasites. J. Biomed. Biotechnol. 2010, 726045. doi: 10.1155/2010/726045
González-Warleta M., Castro-Hermida J. A., Calvo C., Pérez V., Gutiérrez-Expósito D., Regidor-Cerrillo J., et al. (2018). Endogenous transplacental transmission of Neospora caninum during successive pregnancies across three generations of naturally infected sheep. Vet. Res. 49, 106. doi: 10.1186/s13567-018-0601-3
Goodswen S. J., Kennedy P. J., Ellis J. T. (2013). A review of the infection, genetics, and evolution of Neospora caninum: from the past to the present. Infect. Genet. Evol. 13, 133–150. doi: 10.1016/j.meegid.2012.08.012
Gutiérrez-Expósito D., González-Warleta M., Espinosa J., Vallejo-García R., Castro-Hermida J. A., Calvo C., et al. (2020). Maternal immune response in the placenta of sheep during recrudescence of natural congenital infection of Neospora caninum. Vet. Parasitol. 285:109204. doi: 10.1016/j.vetpar.2020.109204
Heckeroth A. R., Tenter A. M. (2007). Immunoanalysis of three litters born to a Doberman bitch infected with Neospora caninum. Parasitol. Res. 100, 837–846. doi: 10.1007/s00436-006-0328-3
Hong D.-P., Radke J. B., White M. W. (2017). Opposing transcriptional mechanisms regulate toxoplasma development. mSphere 2 (1), e00347-16. doi: 10.1128/mSphere.00347-16
Huang S., Holmes M. J., Radke J. B., Hong D.-P., Liu T.-K., White M. W., et al. (2017). Toxoplasma gondii AP2IX-4 Regulates Gene Expression during Bradyzoite Development. mSphere 2 (2), e00054–17. doi: 10.1128/mSphere.00054-17
Ihara F., Nishikawa Y. (2014). Starvation of low-density lipoprotein-derived cholesterol induces bradyzoite conversion in Toxoplasma gondii. Parasitol. Vectors 7, 248. doi: 10.1186/1756-3305-7-248
Jacobs L., Remington J. S., Melton M. L. (1960). The resistance of the encysted form of Toxoplasma gondii. J. Parasitol. 46, 11–21. doi: 10.2307/3275325
Jerome M. E., Radke J. R., Bohne W., Roos D. S., White M. W. (1998). Toxoplasma gondii bradyzoites form spontaneously during sporozoite-initiated development. Infect. Immun. 66, 4838–4844. doi: 10.1128/IAI.66.10.4838-4844.1998
Kano R., Masukata Y., Omata Y., Kobayashi Y., Maeda R., Saito A. (2005). Relationship between type 1/type 2 immune responses and occurrence of vertical transmission in BALB/c mice infected with Neospora caninum. Vet. Parasitol. 129, 159–164. doi: 10.1016/j.vetpar.2005.01.004
Kibe M. K., Coppin A., Dendouga N., Oria G., Meurice E., Mortuaire M., et al. (2005). Transcriptional regulation of two stage-specifically expressed genes in the protozoan parasite Toxoplasma gondii. Nucleic Acids Res. 33, 1722–1736. doi: 10.1093/nar/gki314
Kul O., Atmaca H. T., Anteplioglu T., Ocal N., Canpolat S. (2015). Neospora caninum: the First Demonstration of the Enteroepithelial Stages in the Intestines of a Naturally Infected Dog. J. Comp. Pathol. 153, 9–13. doi: 10.1016/j.jcpa.2015.03.005
Lindsay D. S., Dubey J. P., Blagburn B. L., Toivio-Kinnucan M. (1991). Examination of tissue cyst formation by Toxoplasma gondii in cell cultures using bradyzoites, tachyzoites, and sporozoites. J. Parasitol. 77, 126–132. doi: 10.2307/3282569
Lindsay D. S., Toivio-Kinnucan M. A., Blagburn B. L. (1993). Ultrastructural Determination of Cystogenesis by Various Toxoplasma gondii Isolates in Cell Culture. J. Parasitol. 79, 289. doi: 10.2307/3283523
Lindsay D. S., Ritter D. M., Brake D. (2001). Oocyst excretion in dogs fed mouse brains containing tissue cysts of a cloned line of Neospora caninum. J. Parasitol. 87, 909–911. doi: 10.1645/0022-3395(2001)087[0909:OEIDFM]2.0.CO;2
Lindsay D. S., Dubey J. P. (1990). Infections in mice with tachyzoites and bradyzoites of Neospora caninum (Protozoa: Apicomplexa). J. Parasitol. 76, 410–413. doi: 10.2307/3282676
Lorenzi H., Khan A., Behnke M. S., Namasivayam S., Swapna L. S., Hadjithomas M., et al. (2016). Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nat. Commun. 7, 10147. doi: 10.1038/ncomms10147
Mason R. W. (1978). The detection of Hammondia hammondi in Australia and the identification of a free-living intermediate host. Z. Parasitenkd. 57, 101–106. doi: 10.1007/BF00927150
McAllister M. M., Dubey J. P., Lindsay D. S., Jolley W. R., Wills R. A., McGuire A. M. (1998). Rapid communication. Int. J. Parasitol. 28, 1473–1479. doi: 10.1016/S0020-7519(98)00138-6
McAuley J. B. (2014). Congenital Toxoplasmosis. J. Pediatr. Infect. Dis. Soc 3 (Suppl 1), S30–S35. doi: 10.1093/jpids/piu077
Naguleswaran A., Elias E. V., McClintick J., Edenberg H. J., Sullivan W. J. (2010). Toxoplasma gondii lysine acetyltransferase GCN5-A functions in the cellular response to alkaline stress and expression of cyst genes. PloS Pathog. 6, e1001232. doi: 10.1371/journal.ppat.1001232
Narasimhan J., Joyce B. R., Naguleswaran A., Smith A. T., Livingston M. R., Dixon S. E., et al. (2008). Translation regulation by eukaryotic initiation factor-2 kinases in the development of latent cysts in Toxoplasma gondii. J. Biol. Chem. 283, 16591–16601. doi: 10.1074/jbc.M800681200
Ozgonul C., Besirli C. G. (2017). Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res. 57, 1–12. doi: 10.1159/000449169
Painter H. J., Campbell T. L., Llinás M. (2011). The Apicomplexan AP2 family: integral factors regulating Plasmodium development. Mol. Biochem. Parasitol. 176, 1–7. doi: 10.1016/j.molbiopara.2010.11.014
Radke J. R., Donald R. G., Eibs A., Jerome M. E., Behnke M. S., Liberator P., et al. (2006). Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PloS Pathog. 2, e105. doi: 10.1371/journal.ppat.0020105
Radke J. B., Lucas O., De Silva E. K., Ma Y., Sullivan W. J., Weiss L. M., et al. (2013). ApiAP2 transcription factor restricts development of the Toxoplasma tissue cyst. Proc. Natl. Acad. Sci. U.S.A. 110, 6871–6876. doi: 10.1073/pnas.1300059110
Radke J. B., Worth D., Hong D., Huang S., Sullivan W. J., Wilson E. H., et al. (2018). Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosis. PloS Pathog. 14, e1007035. doi: 10.1371/journal.ppat.1007035
Remington J. S., Cavanaugh E. N. (1965). Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N. Engl. J. Med. 273, 1308–1310. doi: 10.1056/NEJM196512092732404
Riahi H., Dardé M. L., Bouteille B., Leboutet M. J., Pestre-Alexandre M. (1995). Hammondia hammondi cysts in cell cultures. J. Parasitol. 81, 821–824. doi: 10.2307/3283990
Risco-Castillo V., Fernández-García A., Ortega-Mora L. M. (2004). Comparative analysis of stress agents in a simplified in vitro system of Neospora caninum bradyzoite production. J. Parasitol. 90, 466–470. doi: 10.1645/GE-3298
Rooney P. J., Neal L. M., Knoll L. J. (2011). Involvement of a Toxoplasma gondii chromatin remodeling complex ortholog in developmental regulation. PloS One 6, e19570. doi: 10.1371/journal.pone.0019570
Rougier S., Montoya J. G., Peyron F. (2017). Lifelong persistence of toxoplasma cysts: A questionable dogma? Trends Parasitol. 33, 93–101. doi: 10.1016/j.pt.2016.10.007
Saksouk N., Bhatti M. M., Kieffer S., Smith A. T., Musset K., Garin J., et al. (2005). Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii. Mol. Cell. Biol. 25, 10301–10314. doi: 10.1128/MCB.25.23.10301-10314.2005
Scharton-Kersten T. M., Yap G., Magram J., Sher A. (1997). Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261–1273. doi: 10.1084/jem.185.7.1261
Sheffield H. G., Melton M. L., Neva F. A. (1976). Development of Hammondia hammondi in cell cultures. Proc. Helminthol. Soc Wash. 43, 217–225.
Shimura K., Ito S. (1987). Goats as natural intermediate hosts of Hammondia hammondi. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Ser. A: Med. Microbiol. Infect. Diseases Virol. Parasitol. 264, 348–352. doi: 10.1016/S0176-6724(87)80055-X
Smith D. D. (1981). The sarcocystidae: sarcocystis, frenkelia, toxoplasma, besnoitia, hammondia, and cystoisospora 1. J. Protozool. 28, 262–266. doi: 10.1111/j.1550-7408.1981.tb02848.x
Soête M., Camus D., Dubremetz J. F. (1994). Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp. Parasitol 78, 361–370. doi: 10.1006/expr.1994.1039
Sokol S. L., Primack A. S., Nair S. C., Wong Z. S., Tembo M., Verma S. K., et al. (2018). Dissection of the in vitro developmental program of Hammondia hammondi reveals a link between stress sensitivity and life cycle flexibility in Toxoplasma gondii. Elife 7, e36491. doi: 10.7554/eLife.36491
Srivastava S., White M. W., Sullivan W. J. (2020). Toxoplasma gondii AP2XII-2 Contributes to Proper Progression through S-Phase of the Cell Cycle. mSphere 5 (5), e00542–20.. doi: 10.1128/mSphere.00542-20
Subramanian A., Tamayo P., Mootha V. K., Mukherjee S., Ebert B. L., Gillette M. A., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545–15550. doi: 10.1073/pnas.0506580102
Sullivan W. J., Monroy M. A., Bohne W., Nallani K. C., Chrivia J., Yaciuk P., et al. (2003). Molecular cloning and characterization of an SRCAP chromatin remodeling homologue in Toxoplasma gondii. Parasitol. Res. 90, 1–8. doi: 10.1007/s00436-002-0814-1
Sullivan W. J., Narasimhan J., Bhatti M. M., Wek R. C. (2004). Parasite-specific eIF2 (eukaryotic initiation factor-2) kinase required for stress-induced translation control. Biochem. J. 380, 523–531. doi: 10.1042/BJ20040262
Sullivan W. J., Jeffers V. (2012). Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol. Rev. 36, 717–733. doi: 10.1111/j.1574-6976.2011.00305.x
Suzuki Y., Orellana M. A., Schreiber R. D., Remington J. S. (1988). Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240, 516–518. doi: 10.1126/science.3128869
Suzuki Y., Conley F. K., Remington J. S. (1989). Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143, 2045–2050.
Swierzy I. J., Lüder C. G. K. (2015). Withdrawal of skeletal muscle cells from cell cycle progression triggers differentiation of Toxoplasma gondii towards the bradyzoite stage. Cell Microbiol. 17, 2–17. doi: 10.1111/cmi.12342
Tenter A. M., Heckeroth A. R., Weiss L. M. (2000). Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30, 1217–1258. doi: 10.1016/S0020-7519(00)00124-7
Tenter A. M. (2009). Toxoplasma gondii in animals used for human consumption. Mem. Inst. Oswaldo Cruz 104, 364–369. doi: 10.1590/S0074-02762009000200033
Tomavo S., Boothroyd J. C. (1995). Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii. Int. J. Parasitol. 25, 1293–1299. doi: 10.1016/0020-7519(95)00066-B
Vonlaufen N., Müller N., Keller N., Naguleswaran A., Bohne W., McAllister M. M., et al. (2002). Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. Int. J. Parasitol. 32, 1253–1265. doi: 10.1016/s0020-7519(02)00126-1
Waldman B. S., Schwarz D., Wadsworth M. H., Saeij J. P., Shalek A. K., Lourido S. (2020). Identification of a master regulator of differentiation in toxoplasma. Cell 180, 359–372.e16. doi: 10.1016/j.cell.2019.12.013
Walker R., Gissot M., Croken M. M., Huot L., Hot D., Kim K., et al. (2013). The Toxoplasma nuclear factor TgAP2XI-4 controls bradyzoite gene expression and cyst formation. Mol. Microbiol. 87, 641–655. doi: 10.1111/mmi.12121
Wallace G. D. (1975). Observations on a feline coccidium with some characteristics of Toxoplasma and Sarcocystis. Z. Parasitenkd. 46, 167–178. doi: 10.1007/BF00389874
Walzer K. A., Adomako-Ankomah Y., Dam R. A., Herrmann D. C., Schares G., Dubey J. P., et al. (2013). Hammondia hammondi, an avirulent relative of Toxoplasma gondii, has functional orthologs of known T. gondii virulence genes. Proc. Natl. Acad. Sci. U.S.A. 110, 7446–7451. doi: 10.1073/pnas.1304322110
Weiss L. M., Laplace D., Takvorian P. M., Tanowitz H. B., Cali A., Wittner M. (1995). A cell culture system for study of the development of Toxoplasma gondii bradyzoites. J. Eukaryot. Microbiol. 42, 150–157. doi: 10.1111/j.1550-7408.1995.tb01556.x
Weiss L. M., Ma Y. F., Takvorian P. M., Tanowitz H. B., Wittner M. (1998). Bradyzoite development in Toxoplasma gondii and the hsp70 stress response. Infect. Immun. 66, 3295–3302. doi: 10.1128/IAI.66.7.3295-3302.1998
Weiss L. M., Ma Y. F., Halonen S., McAllister M. M., Zhang Y. W. (1999). The in vitro development of Neospora caninum bradyzoites. Int. J. Parasitol. 29, 1713–1723. doi: 10.1016/s0020-7519(99)00130-7
Weiss L. M., Kim K. (2000). The development and biology of bradyzoites of Toxoplasma gondii. Front. Biosci. 5, D391–D405.
Williams D. J. L., Hartley C. S., Björkman C., Trees A. J. (2009). Endogenous and exogenous transplacental transmission of Neospora caninum - how the route of transmission impacts on epidemiology and control of disease. Parasitology 136, 1895–1900. doi: 10.1017/S0031182009990588
Williams D. J. L., Trees A. J. (2006). Protecting babies: vaccine strategies to prevent foetopathy in Neospora caninum-infected cattle. Parasite Immunol. 28, 61–67. doi: 10.1111/j.1365-3024.2005.00809.x
Yap G. S., Scharton-Kersten T., Charest H., Sher A. (1998). Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160, 1340–1345.
Keywords: Toxoplasma gondii, Hammondia hammondi, Neospora caninum, bradyzoite, tissue cysts
Citation: Sokol-Borrelli SL, Coombs RS and Boyle JP (2020) A Comparison of Stage Conversion in the Coccidian Apicomplexans Toxoplasma gondii, Hammondia hammondi, and Neospora caninum. Front. Cell. Infect. Microbiol. 10:608283. doi: 10.3389/fcimb.2020.608283
Received: 19 September 2020; Accepted: 06 November 2020;
Published: 03 December 2020.
Edited by:
Mathieu Gissot, Centre National de la Recherche Scientifique (CNRS), FranceReviewed by:
Sébastien Besteiro, Université de Montpellier, FranceCarsten Lüder, Universitätsmedizin Göttingen, Germany
Copyright © 2020 Sokol-Borrelli, Coombs and Boyle. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jon P. Boyle, Ym95bGVqQHBpdHQuZWR1